Exhibit 31.1

                                  CERTIFICATION

         Pursuant to the requirements of Rules 13a-14 of the Securities Exchange
Act of 1934, as amended, James R. Musick provides the following certification.

         I, James R. Musick, President, Chief Executive Officer, Chairman of the
Board of Directors and Principal Financial Officer of Vitro Diagnostics, Inc.
("Company") certify that:

          1.   I have reviewed this quarterly report on Form 10-QSB of the
               Company;

          2.   Based on my knowledge, this quarterly report does not contain any
               untrue statement of a material fact or omit to state a material
               fact necessary to make the statements made, in light of the
               circumstances under which such statements were made, not
               misleading with respect to the period covered by this quarterly
               report;

          3.   Based on my knowledge, the financial statements, and other
               financial information included in the quarterly report, fairly
               present in all material respects the financial condition, results
               of operations and cash flows of the Company as of, and for, the
               periods presented in this quarterly report;

          4.   I am responsible for establishing and maintaining disclosure
               controls and procedures (as defined in Exchange Act Rules 13a-14
               and 15-d-14) for the registrant and have designed such disclosure
               controls and procedures to ensure that material information
               relating to the Company is made know to me by others,
               particularly during the period in which this quarterly report is
               being prepared;

          5.   I have disclosed, based on my most recent evaluation, to the
               Company's auditors and the audit committee of our board of
               directors (or persons performing the equivalent functions):

               a.   All significant deficiencies in the design or operation of
                    internal controls which could adversely affect the Company's
                    ability to record, process, summarize and report financial
                    date and have identified for the Company's auditors any
                    material weaknesses in internal controls, and

               b.   Any fraud, whether or not material, that involves management
                    or other employees which have a significant role in the
                    Company's internal controls; and

          6.   I have indicated in this quarterly report whether or not there
               were significant changes in internal control or in other factors
               that could significantly affect internal controls subsequent to
               the date of my most recent evaluation, including any corrective
               actions with regard to significant deficiencies and material
               weaknesses.

Date: March 14, 2008
                                         By: /s/ James R. Musick
                                             -----------------------------------
                                             James R. Musick, President,
                                             Chief Executive Officer,
                                             Chairman of the Board of Directors,
                                             and Principal Financial Officer